Lonidamine plus Epirubicin and Cyclophosphamide in Advanced Breast Cancer. A Phase II Study

By Gardin G.   Barone C.   Nascimben O.   Ianniello G.   Sturba F.   Contu A.   Pronzato P.   Rosso R.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 176-177

Elsevier

Access to resources Recommend Favorite

Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

By Hatschek T.   Carlsson L.   Einbeigi Z.   Lidbrink E.   Linderholm B.   Lindh B.   Loman N.   Malmberg M.   Rotstein S.   Söderberg M.   Sundquist M.   Walz T.   Hellström M.   Svensson H.   Åström G.   Brandberg Y.   Carstensen J.   Fernö M.   Bergh J.  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 939-947

Springer Publishing Company

Access to resources Recommend Favorite

First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status

By                

Experimental and Therapeutic Medicine, Vol. 4, Iss. 4, 2012-01 ,pp. : 562-568

Spandidos Publications

Access to resources Recommend Favorite

A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG

By Banerjee S.   Rustin G.   Paul J.   Williams C.   Pledge S.   Gabra H.   Skailes G.   Lamont A.   Hindley A.   Goss G.   Gilby E.   Hogg M.   Harper P.   Kipps E.   Lewsley L-A   Hall M.   Vasey P.   Kaye S. B.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 679-687

Oxford University Press

Access to resources Recommend Favorite

Clinical and pharmacokinetic data of a docetaxel-epirubicin combination in metastatic breast cancer

By Airoldi M.  

Breast Cancer Research and Treatment, Vol. 70, Iss. 3, 2001-12 ,pp. : 185-195

Springer Publishing Company

Access to resources Recommend Favorite